World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
73
Citations
29698
World Ranking
19544
National Ranking
9731

Overview

Robert S. Mannel is affiliated with the University of Oklahoma Health Sciences Center in the United States and has contributed extensively to the field of Medicine, with a focus on Reproductive Medicine, Obstetrics and Gynecology, Surgery, Radiology, Nuclear Medicine and Imaging, and Oncology.

Their work primarily addresses clinical and research issues related to ovarian, endometrial, and cervical cancers. The main topics of Robert S. Mannel's research include:

  • Ovarian cancer diagnosis and treatment
  • Endometrial and Cervical Cancer Treatments
  • Cervical Cancer and HPV Research
  • Intraperitoneal and Appendiceal Malignancies
  • Radiomics and Machine Learning in Medical Imaging
  • Colorectal and Anal Carcinomas
  • AI in cancer detection

They have published numerous papers in leading oncology and gynecologic journals. Some notable recent publications are:

  • Recent advances and clinical applications of deep learning in medical image analysis, 2022, Medical Image Analysis
  • Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer, 2023, New England Journal of Medicine
  • Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209), 2020, Journal of Clinical Oncology
  • Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study, 2023, Journal of Clinical Oncology
  • Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II, 2021, Journal of Clinical Oncology

The scientist frequently collaborates with several co-authors, with whom they have multiple joint publications. Frequent collaborators include:

  • Kathleen N. Moore
  • Krishnansu S. Tewari
  • Bradley J. Monk
  • Joan L. Walker
  • Carol Aghajanian

Publication venues where Robert S. Mannel's work often appears include:

  • Gynecologic Oncology
  • Journal of Clinical Oncology
  • Annals of Oncology
  • Obstetrical & Gynecological Survey
  • International Journal of Gynecological Cancer

Best Publications

  • Incorporation of bevacizumab in the primary treatment of ovarian cancer

    Robert A. Burger;Mark F. Brady;Michael A. Bookman;Gini F. Fleming

  • Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

    Robert F. Ozols;Brian N. Bundy;Benjamin E. Greer;Jeffrey M. Fowler

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Laparoscopy Compared With Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group Study LAP2

    Joan L. Walker;Marion R. Piedmonte;Nick M. Spirtos;Scott M. Eisenkop

  • Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

    Marcus E. Randall;Virginia L. Filiaci;Hyman Muss;Nick M. Spirtos

  • Inherited Mutations in Women With Ovarian Carcinoma

    Barbara M. Norquist;Maria I. Harrell;Mark F. Brady;Tom Walsh

  • Recurrence and Survival After Random Assignment to Laparoscopy Versus Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group LAP2 Study

    Joan L. Walker;Marion R. Piedmonte;Nick M. Spirtos;Scott M. Eisenkop

  • 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).

    A du Bois;M Quinn;T Thigpen;J Vermorken

  • Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial

    Robert L. Coleman;Mark F. Brady;Thomas J. Herzog;Paul Sabbatini

  • Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

    Franz X. Schaub;Varsha Dhankani;Ashton C. Berger;Mihir Trivedi

  • Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study

    John Farley;William E Brady;Vinod Vathipadiekal;Heather A Lankes

  • Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial

    Martee L. Hensley;John A. Blessing;Robert Mannel;Peter G. Rose

  • Final overall survival of a randomized trial of bevacizumab for primary treatment of ovarian cancer

    Krishnansu S. Tewari;Robert A. Burger;Danielle Enserro;Barbara M. Norquist

  • Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

    Joshua D. Campbell;Joshua D. Campbell;Joshua D. Campbell;Christina Yau;Christina Yau;Reanne Bowlby;Yuexin Liu

  • A Gynecologic Oncology Group Randomized Phase III Trial of Whole Abdominal Irradiation (WAI) vs Cisplatin-Ifosfamide and Mesna (CIM) as Post-Surgical Therapy in Stage I-IV Carcinosarcoma (CS) of the Uterus

    Aaron H. Wolfson;Mark F. Brady;Thomas Rocereto;Robert S. Mannel

  • Late-Breaking Abstract 1: Randomized phase III noninferiority trial of first line chemotherapy for metastatic or recurrent endometrial carcinoma: A Gynecologic Oncology Group study

    D. Miller;V. Filiaci;G. Fleming;R. Mannel

  • Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a gynecologic oncology group study

    Mahesh A Varia;Brian N Bundy;Gunter Deppe;Robert Mannel

  • Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early-Stage Endometrial Cancer

    Marcus E. Randall;Virginia Filiaci;D. Scott McMeekin;Vivian Von Gruenigen

  • Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer

    Robert L. Coleman;Nick M. Spirtos;Danielle Enserro;Thomas J. Herzog

Frequent Co-Authors

Joan L. Walker
Joan L. Walker University of California, Berkeley
Kathleen N. Moore
Kathleen N. Moore University of Oklahoma Health Sciences Center
Michael J. Birrer
Michael J. Birrer University of Arkansas for Medical Sciences
Bradley J. Monk
Bradley J. Monk University of Arizona
David E. Cohn
David E. Cohn The Ohio State University
Robert L. Coleman
Robert L. Coleman The University of Texas MD Anderson Cancer Center
Gini F. Fleming
Gini F. Fleming University of Chicago
David M. O'Malley
David M. O'Malley The Ohio State University
Carol Aghajanian
Carol Aghajanian Memorial Sloan Kettering Cancer Center
Elizabeth M. Swisher
Elizabeth M. Swisher University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn't always mean following the traditional medical school route. Many students are opting for alternative paths like nursing or medical billing. For example, if you're eager to jump into a nursing career, there are online direct entry msn programs designed for non-nurses, which let you earn a graduate nursing degree in less time.

If gaining admission is your primary concern, consider nursing programs with high acceptance rates. These schools can offer a more accessible entry point to a healthcare career. Additionally, for those avoiding standardized tests, there are nursing school that doesn't require teas or HESI exams, allowing a smoother application process.

For those interested in healthcare support roles, pursuing medical billing and coding online is a popular choice. Many reputable programs offer help to pay for your education—check out the medical billing and coding financial aid resources to see what’s available.

Each of these options provides flexible, practical avenues to join the growing healthcare field without the lengthy commitment or requirements of medical school.

Best Scientists Citing Robert S. Mannel

Trending Scientists